uniQure N.V. (QURE)
NASDAQ: QURE · Real-Time Price · USD
16.61
+1.65 (11.03%)
Jun 5, 2025, 4:00 PM - Market closed
uniQure Employees
uniQure had 209 employees as of December 31, 2024. The number of employees decreased by 271 or -56.46% compared to the previous year.
Employees
209
Change (1Y)
-271
Growth (1Y)
-56.46%
Revenue / Employee
$96,656
Profits / Employee
-$1,041,029
Market Cap
909.37M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
QURE News
- 3 days ago - uniQure Provides Regulatory Update on AMT-130 for Huntington's Disease - GlobeNewsWire
- 8 days ago - uniQure's AMT-130 Gene Therapy Warrants An Upgrade - Seeking Alpha
- 17 days ago - Corbus Pharmaceuticals Names Industry Veteran Rachelle Jacques as Board Chair - GlobeNewsWire
- 27 days ago - uniQure N.V. (QURE) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 27 days ago - uniQure Announces First Quarter 2025 Financial Results and Highlights of Recent Company Progress - GlobeNewsWire
- 4 weeks ago - uniQure: A Buy For Their Lead In Huntington's Program, In Light Of PTC's Data - Seeking Alpha
- 4 weeks ago - uniQure to Announce First Quarter 2025 Financial Results - GlobeNewsWire
- 6 weeks ago - uniQure: Bullish On Near-Term Catalysts After Breakthrough Therapy Designation For AMT-130 - Seeking Alpha